Eribulin Mesylate
NDC 0781-3391, eribulin mesylate, injection, from Sandoz Inc.
- Product NDC
- 0781-3391
- Status
- Listed
- Labeler
- Sandoz Inc
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214310
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0781-3391 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ERIBULIN MESYLATE.5 mg/mL
Pharmacologic classes
Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0781-3391-94 | 00781339194 | 1 VIAL in 1 CARTON (0781-3391-94) / 2 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d122f0a4-aff7-49f7-8cf1-06bc2883ad43Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0781-3391
Use it
Look up 0781-3391 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0781-3391 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0781-3391. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.